🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with anti-thrombotic properties of glp-1 receptor activation? Page 5

Has anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

rachel_ABQ Tue, Nov 18, 2025 at 5:17 PM 30 replies 1,490 viewsPage 5 of 6
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Dec 1, 2025 at 8:24 AM#21
claudia_zurich said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Coming at claudia_zurich’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Dec 1, 2025 at 1:24 PM
37 12Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 34 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Dec 5, 2025 at 5:20 PM#22

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: Dec 5, 2025 at 10:20 PM
36 11stefan_berlin, Dr.EM_Chicago, pete_RVA and 33 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Dec 10, 2025 at 2:14 AM#23

Following on from claudia_zurich — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

35 10JessicaM_2024, TomFromTexas, mike.trainer_LA and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Dec 14, 2025 at 11:05 AM#24
TrialTracker_MD said:
Say what you would expect to see if you were wrong, before you look.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

34 9PharmHunterJen, TomTeleRx, DoseLogDan and 31 others
Reply Quote Save Share Report
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Dec 18, 2025 at 7:54 PM#25
TrialTracker_MD said:
Say what you would expect to see if you were wrong, before you look.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

33 8tane_welly, Dr.PathRoch, mona_PHX and 30 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register